Circulating levels of sIL6R have been found to be elevated (in comparison to healthy individuals) in patients with different cancer types, including myeloma, leukaemia, bladder, prostate and hepatocellular cancer, with higher levels associated with tumour grade, volume or disease spread [152,153,154,155,156,157]. The gene discussed is IL6R; the disease is cancer.